The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients

Su, T., Ying, Z., Lu, X., He, T., Song, Y., Wang, X., Ping, L., Xie, Y., Tu, M., Liu, G., Qi, F., Ding, Y., Jing, H. and Zhu, J.  The clinical outcomes of fresh versus cryopreserved CD19-directed chimeric antigen receptor T cells in non-Hodgkin lymphoma patients.  Cryobiology.  2020; 96, 106-113.  doi: 10.1016/j.cryobiol.2020.07.009

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.